{"id":8131,"date":"2021-12-16T12:19:53","date_gmt":"2021-12-16T17:19:53","guid":{"rendered":"https:\/\/puyapeptide.net\/product\/vapreotide-acetate-rc-160-cas-103222-11-3-behandling-til-akut-esophageal-variceal-bloedning\/"},"modified":"2021-12-16T12:19:53","modified_gmt":"2021-12-16T17:19:53","slug":"vapreotide-acetate-rc-160-cas-103222-11-3-behandling-til-akut-esophageal-variceal-bloedning","status":"publish","type":"product","link":"https:\/\/puyapeptide.net\/da\/product\/vapreotide-acetate-rc-160-cas-103222-11-3-behandling-til-akut-esophageal-variceal-bloedning\/","title":{"rendered":"Vapreotide Acetate\/ RC 160 CAS 103222-11-3 Behandling Til akut esophageal variceal bl\u00f8dning"},"content":{"rendered":"

Vapreotide Acetate\/ RC 160 CAS 103222-11-3 Behandling Til akut esophageal variceal bl\u00f8dning<\/strong><\/h2>\n

Produktnavn: VAPREOTIDE
\nSynonymer: D-Phe-Cys-Tyr-D-Trp-Lys-Val-Cys-Trp-NH2 (Disulfidbro Cys2-Cys7);HD-Phe-Cys-Tyr-D -Trp-Lys-Val-Cys-Trp-NH2;D-Phe-Cys-Trp-D-Trp-Lys-Val-Cys-Trp-CONH2(disulfid Cys2-Cys7);Vapreotid, RC-160;RC-160 ;VAPREOTIDE;D-PHE-CYS-TYR-D-TRP-LYS-VAL-CYS-TRP-NH2;FCYWKVCW-NH2
\nCAS: 103222-11-3
\nMF: C57H70N12O9S2
\nMW: 1131.
\nEINECS:
\nProduktkategorier: Somatostatinreceptor
\nMol Fil: 103222-11-3.mol<\/p>\n

H3Pharma har erhvervet den verdensomsp\u00e6ndende forskningsudviklings- og kommercielle licens for vaptan fra Debiopharm i Schweiz. 2001 New England Journal of Medicine rapporterede formuleringen med \u00f8jeblikkelig frigivelse, som blev klinisk testet og bevist af Chemicalbook til tidlig brug i behandlingen af akut esophageal. I 2004 udviklede og fremstillede Debiopharms datterselskab, den canadiske cancer- og endokrinologispecialist H3Pharma, et nyt l\u00e6gemiddel .<\/p>\n

Vapreotide Acetate\/ RC 160 CAS 103222-11-3 Kemiske egenskaber<\/strong>
\nKogepunkt 1540,9\u00b165,0 \u00b0C(Forudsagt)
\ndensitet 1,40\u00b10,1 g\/cm3(Forudsagt)
\nlagring Midlertidig. \u221220\u00b0C
\npka 9,90\u00b10,15(forudsagt)<\/p>\n

Funktion og anvendelse af vapreotideacetat\/RC 160 CAS 103222-11-3<\/strong>
\n1. Formuleringen med \u00f8jeblikkelig frigivelse af Sanvar, en somatostatinanalog , bruges til behandling af akut esophageal variceal bl\u00f8dning (EVB).
\n2.Sanvar bruges forud for endoskopisk intervention for at kontrollere bl\u00f8dninger og forhindre genbl\u00f8dning i de kritiske fem dage efter bl\u00f8dningens begyndelse. EVB er en livstruende tilstand, og d\u00f8deligheden er h\u00f8j (ca. 15 % til 25 %) i de f\u00f8rste seks uger efter bl\u00f8dningen. EVB er \u00e5rsagen til omkring 70 % af gastrointestinale bl\u00f8dninger hos patienter, der lider af levercirrhose.
\n3.Sanvar (vapreotidacetat) er en syntetisk octapeptidanalog af det naturligt forekommende somatostatinhormon. Det har lignende farmakologiske egenskaber som naturligt somatostatin, men udviser en l\u00e6ngere virkningsvarighed. Det er den eneste somatostatinanalog, der har vist statistisk signifikante fordele ved tidlig behandling af EVB i forbindelse med endoskopisk terapi i et placebokontrolleret klinisk studie (Cal\u00e8s et al. New England Journal of Medicine, 2001). Kontrol af bl\u00f8dning med overlevelse efter fem dage blev opn\u00e5et oftere med Sanvar (p=0,021) end med placebo. Ekstra<\/p>\n","protected":false},"excerpt":{"rendered":"

Produktnavn: VAPREOTIDE
\nCAS: 103222-11-3
\nMF: C57H70N12O9S2
\nMW: 1131.37
\nMol Fil: 103222-11-3.mol<\/p>\n","protected":false},"featured_media":2119,"comment_status":"open","ping_status":"closed","template":"","meta":{"om_disable_all_campaigns":false,"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"site-sidebar-layout":"default","site-content-layout":"default","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}}},"product_brand":[],"product_cat":[531],"product_tag":[1527],"class_list":{"0":"post-8131","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-andre-peptider","7":"product_tag-vapreotide-acetate-rc-160-cas-103222-11-3-treatment-for-acute-esophageal-variceal-bleeding-da","8":"desktop-align-left","9":"tablet-align-left","10":"mobile-align-left","12":"first","13":"instock","14":"shipping-taxable","15":"product-type-simple"},"_links":{"self":[{"href":"https:\/\/puyapeptide.net\/da\/wp-json\/wp\/v2\/product\/8131","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/puyapeptide.net\/da\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/puyapeptide.net\/da\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/puyapeptide.net\/da\/wp-json\/wp\/v2\/comments?post=8131"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/puyapeptide.net\/da\/wp-json\/wp\/v2\/media\/2119"}],"wp:attachment":[{"href":"https:\/\/puyapeptide.net\/da\/wp-json\/wp\/v2\/media?parent=8131"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/puyapeptide.net\/da\/wp-json\/wp\/v2\/product_brand?post=8131"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/puyapeptide.net\/da\/wp-json\/wp\/v2\/product_cat?post=8131"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/puyapeptide.net\/da\/wp-json\/wp\/v2\/product_tag?post=8131"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}